Tag: SYRE

Insiders Updates

Spyre Therapeutics Inc’s recent filing unveils that its Director Albers Jeffrey W. unloaded Company’s shares for reported $0.25 million on

Stock Earnings

Spyre Therapeutics Inc.’s recently made public that its Director SESSIONS, LLC acquired Company’s shares for reported $0.24 million on Oct

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Spyre Therapeutics

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

In a filing, Spyre Therapeutics Inc. revealed its Chief Financial Officer Burrows Scott L unloaded Company’s shares for reported $0.52